{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:18:24Z","timestamp":1778584704493,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Deanship of Scientific Research, Jordan University of Science and Technology","award":["20210030"],"award-info":[{"award-number":["20210030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46187-5","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T15:05:47Z","timestamp":1774796747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of angiotensin converting enzyme type 2 serum level and gene polymorphisms with multiple sclerosis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9857-4966","authenticated-orcid":false,"given":"Maha S.","family":"Al-Keilani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba M.","family":"Abdelrazeq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagham N.","family":"Hendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saied A.","family":"Jaradat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"key":"46187_CR1","doi-asserted-by":"crossref","unstructured":"McGinley, M. P., Goldschmidt, C. H. & Rae-Grant, A. D. Diagnosis and treatment of multiple sclerosis: a review, Jama, vol. 325, no. 8, pp. 765\u2013779, (2021).","DOI":"10.1001\/jama.2020.26858"},{"key":"46187_CR2","doi-asserted-by":"publisher","first-page":"812147","DOI":"10.3389\/fneur.2021.812147","volume":"12","author":"L Ross","year":"2022","unstructured":"Ross, L. et al. Women\u2019s health in multiple sclerosis: a scoping review. Front. Neurol. 12, 812147 (2022).","journal-title":"Front. Neurol."},{"issue":"6","key":"46187_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/eji.202149757","volume":"52","author":"B Engelhardt","year":"2022","unstructured":"Engelhardt, B., Comabella, M. & Chan, A. Multiple sclerosis: Immunopathological heterogeneity and its implications. Eur. J. Immunol. 52 (6), 869\u2013881 (2022).","journal-title":"Eur. J. Immunol."},{"key":"46187_CR4","doi-asserted-by":"crossref","unstructured":"Stys, P. K. & Tsutsui, S. Recent advances in understanding multiple sclerosis, F1000Research, vol. 8, (2019).","DOI":"10.12688\/f1000research.20906.1"},{"issue":"sup2","key":"46187_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1586\/14737175.2013.865866","volume":"13","author":"A Ascherio","year":"2013","unstructured":"Ascherio, A. Environmental factors in multiple sclerosis. Expert Rev. Neurother. 13 (sup2), 3\u20139 (2013).","journal-title":"Expert Rev. Neurother."},{"key":"46187_CR6","doi-asserted-by":"publisher","first-page":"175628642110076","DOI":"10.1177\/17562864211007687","volume":"14","author":"S Haase","year":"2021","unstructured":"Haase, S. & Linker, R. A. Inflammation in multiple sclerosis. Ther. Adv. Neurol. Disord. 14, 17562864211007687 (2021).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"46187_CR7","doi-asserted-by":"crossref","unstructured":"Frischer, J. M. et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains, Brain, vol. 132, no. 5, pp. 1175\u20131189, (2009).","DOI":"10.1093\/brain\/awp070"},{"key":"46187_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2013.05.010","volume":"333","author":"H Lassmann","year":"2013","unstructured":"Lassmann, H. Pathology and disease mechanisms in different stages of multiple sclerosis. J. Neurol. Sci. 333, 1\u20132 (2013).","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"46187_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.it.2016.08.001","volume":"37","author":"M Schwartz","year":"2016","unstructured":"Schwartz, M. & Deczkowska, A. Neurological disease as a failure of brain\u2013immune crosstalk: the multiple faces of neuroinflammation. Trends Immunol. 37 (10), 668\u2013679 (2016).","journal-title":"Trends Immunol."},{"issue":"8","key":"46187_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/1440-1681.12137","volume":"40","author":"C Sumners","year":"2013","unstructured":"Sumners, C. et al. Protective arms of the renin\u2013angiotensin-system in neurological disease. Clin. Exp. Pharmacol. Physiol. 40 (8), 580\u2013588 (2013).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"46187_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11481-019-09894-7","volume":"15","author":"RE Stone","year":"2020","unstructured":"Stone, R. E. et al. Activation of the protective arm of the renin angiotensin system in demyelinating disease. J. Neuroimmune Pharmacol. 15, 249\u2013263 (2020).","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"9","key":"46187_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2174\/0929866524666170822120258","volume":"24","author":"AF Almeida-Santos","year":"2017","unstructured":"Almeida-Santos, A. F., Kangussu, L. M. & Campagnole-Santos, M. J. The renin-angiotensin system and the neurodegenerative diseases: a brief review. Protein Pept. Lett. 24 (9), 841\u2013853 (2017).","journal-title":"Protein Pept. Lett."},{"key":"46187_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2016.02.026","volume":"363","author":"M \u017divkovi\u0107","year":"2016","unstructured":"\u017divkovi\u0107, M. et al. Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis. J. Neurol. Sci. 363, 29\u201332 (2016).","journal-title":"J. Neurol. Sci."},{"key":"46187_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-020-00225-w","volume":"25","author":"DY Cao","year":"2020","unstructured":"Cao, D. Y. et al. Role of angiotensin-converting enzyme in myeloid cell immune responses. Cell. Mol. Biol. Lett. 25, 1\u201312 (2020).","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"3","key":"46187_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0304-3940(00)01184-8","volume":"287","author":"CS Constantinescu","year":"2000","unstructured":"Constantinescu, C. S., Goodman, D. B., Hilliard, B., Wysocka, M. & Cohen, J. A. Murine macrophages stimulated with central and peripheral nervous system myelin or purified myelin proteins release inflammatory products. Neurosci. Lett. 287 (3), 171\u2013174 (2000).","journal-title":"Neurosci. Lett."},{"key":"46187_CR16","doi-asserted-by":"crossref","unstructured":"Stegbauer, J. et al. Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system, Proceedings of the National Academy of Sciences, vol. 106, no. 35, pp. 14942\u201314947, (2009).","DOI":"10.1073\/pnas.0903602106"},{"issue":"3","key":"46187_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3109\/08923979509016382","volume":"17","author":"CS Constantinescu","year":"1995","unstructured":"Constantinescu, C. S., Ventura, E., Hilliard, B. & Rostami, A. Effects of the angiotensin converting enzyme inhibitor captopril on experimental autoimmune encephalomyelitis. Immunopharmacol. Immunotoxicol. 17 (3), 471\u2013491 (1995).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"46187_CR18","doi-asserted-by":"crossref","unstructured":"Platten, M. et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1-and TH17-mediated autoimmunity, Proceedings of the National Academy of Sciences, vol. 106, no. 35, pp. 14948\u201314953, (2009).","DOI":"10.1073\/pnas.0903958106"},{"issue":"8","key":"46187_CR19","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/archneur.1997.00550200068012","volume":"54","author":"CS Constantinescu","year":"1997","unstructured":"Constantinescu, C. S., Goodman, D. B., Grossman, R. I., Mannon, L. J. & Cohen, J. A. Serum angiotensin-converting enzyme in multiple sclerosis. Arch. Neurol. 54 (8), 1012\u20131015 (1997).","journal-title":"Arch. Neurol."},{"issue":"2","key":"46187_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/1352458508097923","volume":"15","author":"M Kawajiri","year":"2009","unstructured":"Kawajiri, M. et al. Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis. Multiple Scler. J. 15 (2), 262\u2013265 (2009).","journal-title":"Multiple Scler. J."},{"issue":"1","key":"46187_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.phrs.2012.10.014","volume":"67","author":"T Jiang","year":"2013","unstructured":"Jiang, T. et al. Angiotensin-(1\u20137) modulates renin\u2013angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats. Pharmacol. Res. 67 (1), 84\u201393 (2013).","journal-title":"Pharmacol. Res."},{"issue":"2","key":"46187_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1042\/CS20120652","volume":"125","author":"MM Gironacci","year":"2013","unstructured":"Gironacci, M. M., Carbajosa, N. A. L., Goldstein, J. & Cerrato, B. D. Neuromodulatory role of angiotensin-(1\u20137) in the central nervous system. Clin. Sci. 125 (2), 57\u201365 (2013).","journal-title":"Clin. Sci."},{"key":"46187_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s12253-018-0471-z","volume":"25","author":"X Li","year":"2019","unstructured":"Li, X., Wang, X., Xie, J., Liang, B. & Wu, J. Suppression of angiotensin-(1\u20137) on the disruption of blood-brain barrier in rat of brain glioma. Pathol. Oncol. Res. 25, 429\u2013435 (2019).","journal-title":"Pathol. Oncol. Res."},{"key":"46187_CR24","doi-asserted-by":"crossref","unstructured":"Li, S. et al. Association between circulating angiotensin-converting enzyme 2 and cardiac remodeling in hypertensive patients, Peptides, vol. 90, pp. 63\u201368, (2017).","DOI":"10.1016\/j.peptides.2017.02.007"},{"key":"46187_CR25","doi-asserted-by":"publisher","first-page":"117727192211251","DOI":"10.1177\/11772719221125123","volume":"17","author":"A Bani Hani","year":"2022","unstructured":"Bani Hani, A. et al. Serum ACE2 level is Associated with severe SARS-CoV-2 infection: a cross-sectional observational study. Biomark. Insights. 17, 11772719221125123 (2022).","journal-title":"Biomark. Insights"},{"key":"46187_CR26","doi-asserted-by":"crossref","unstructured":"Lee, J. H. et al. Soluble ACE2 and TMPRSS2 levels in the serum of asthmatic patients. Journal Korean Med. Science, 37, 8, (2022).","DOI":"10.3346\/jkms.2022.37.e65"},{"issue":"2","key":"46187_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejr.2023.12.003","volume":"46","author":"NA Azab","year":"2024","unstructured":"Azab, N. A., Mohamed, S. A., Hanna, M. O. F. & Hussein, W. H. Serum levels of angiotensin converting enzyme 2 in patients with systemic sclerosis. Egypt. Rheumatologist. 46 (2), 51\u201355 (2024).","journal-title":"Egypt. Rheumatologist"},{"key":"46187_CR28","doi-asserted-by":"publisher","first-page":"104621","DOI":"10.1016\/j.micpath.2020.104621","volume":"150","author":"H Singh","year":"2021","unstructured":"Singh, H., Choudhari, R., Nema, V. & Khan, A. A. ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease. Microb. Pathog. 150, 104621 (2021).","journal-title":"Microb. Pathog."},{"issue":"5","key":"46187_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41440-018-0166-6","volume":"42","author":"Y Luo","year":"2019","unstructured":"Luo, Y. et al. Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang. Hypertens. Res. 42 (5), 681\u2013689 (2019).","journal-title":"Hypertens. Res."},{"key":"46187_CR30","first-page":"19","volume":"17","author":"J Chaoxin","year":"2013","unstructured":"Chaoxin, J. et al. The influence of angiotensin-converting enzyme 2 gene polymorphisms on type 2 diabetes mellitus and coronary heart disease. Eur. Rev. Med. Pharmacol. Sci. 17, 19 (2013).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"46187_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-018-0771-3","volume":"17","author":"C Liu","year":"2018","unstructured":"Liu, C. et al. ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus. Cardiovasc. Diabetol. 17, 1\u201311 (2018).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"46187_CR32","doi-asserted-by":"publisher","first-page":"10505","DOI":"10.1038\/s41598-024-61254-5","volume":"14","author":"M Pan","year":"2024","unstructured":"Pan, M. et al. Genetic variations in ACE2 gene associated with metabolic syndrome in southern China: a case\u2013control study. Sci. Rep. 14 (1), 10505 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"46187_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40246-023-00501-8","volume":"17","author":"F Sheikhian","year":"2023","unstructured":"Sheikhian, F. et al. The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants. Hum. Genomics. 17 (1), 54 (2023).","journal-title":"Hum. Genomics"},{"key":"46187_CR34","doi-asserted-by":"publisher","first-page":"564741","DOI":"10.3389\/fgene.2020.564741","volume":"11","author":"A Srivastava","year":"2020","unstructured":"Srivastava, A. et al. Genetic association of ACE2 rs2285666 polymorphism with COVID-19 spatial distribution in India. Front. Genet. 11, 564741 (2020).","journal-title":"Front. Genet."},{"issue":"5","key":"46187_CR35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/iji.12598","volume":"49","author":"F Khalilzadeh","year":"2022","unstructured":"Khalilzadeh, F. et al. Angiotensin-converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID\u201019 severity in Iranian population. Int. J. Immunogenet. 49 (5), 325\u2013332 (2022).","journal-title":"Int. J. Immunogenet."},{"issue":"2","key":"46187_CR36","doi-asserted-by":"publisher","first-page":"e0263140","DOI":"10.1371\/journal.pone.0263140","volume":"17","author":"M Sabater Molina","year":"2022","unstructured":"Sabater Molina, M. et al. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease. PloS one. 17 (2), e0263140 (2022).","journal-title":"PloS one"},{"issue":"2","key":"46187_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17 (2), 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"issue":"4","key":"46187_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1756285610374117","volume":"3","author":"MD Goldman","year":"2010","unstructured":"Goldman, M. D., Motl, R. W. & Rudick, R. A. Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Ther. Adv. Neurol. Disord. 3 (4), 229\u2013239 (2010).","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"3","key":"46187_CR39","doi-asserted-by":"publisher","first-page":"099","DOI":"10.4274\/tnd.75318","volume":"22","author":"S Sevim","year":"2016","unstructured":"Sevim, S. Relapses in multiple sclerosis: definition, pathophysiology, features, imitators, and treatment. Turkish J. Neurol. 22 (3), 099\u2013108 (2016).","journal-title":"Turkish J. Neurol."},{"key":"46187_CR40","doi-asserted-by":"crossref","unstructured":"Unal, I. Defining an optimal cut-point value in ROC analysis: an alternative approach, Computational and mathematical methods in medicine, vol. 2017, no. 1, p. 3762651, (2017).","DOI":"10.1155\/2017\/3762651"},{"issue":"5","key":"46187_CR41","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue, M. et al. A novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circul. Res. 87 (5), e1\u2013e9 (2000).","journal-title":"Circul. Res."},{"key":"46187_CR42","doi-asserted-by":"crossref","unstructured":"Bennion, D. M., Haltigan, E., Regenhardt, R. W. & Steckelings, U. M. and C. J. C. h. r. Sumners, Neuroprotective mechanisms of the ACE2\u2013Angiotensin-(1\u20137)\u2013Mas axis in stroke, vol. 17, no. 2, p. 3, (2015).","DOI":"10.1007\/s11906-014-0512-2"},{"key":"46187_CR43","doi-asserted-by":"crossref","unstructured":"Lennol, M. P. et al. Increased Cerebrospinal Fluid Angiotensin-Converting Enzyme 2 Fragments as a Read-Out of Brain Infection in Patients With COVID-19 Encephalopathy, vol. 231, no. 5, pp. e929-e940, (2025).","DOI":"10.1093\/infdis\/jiaf093"},{"key":"46187_CR44","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Ayll\u00f3n, M. S. et al. Plasma ACE2 species are differentially altered in COVID\u201019 patients, vol. 35, no. 8, p. e21745, (2021).","DOI":"10.1096\/fj.202100051R"},{"key":"46187_CR45","doi-asserted-by":"crossref","unstructured":"Xia, J., Broadhurst, D. I., Wilson, M. & Wishart, D. S. Translational biomarker discovery in clinical metabolomics: an introductory tutorial, Metabolomics, vol. 9, pp. 280\u2013299, (2013).","DOI":"10.1007\/s11306-012-0482-9"},{"key":"46187_CR46","doi-asserted-by":"crossref","unstructured":"KOlakovic, A., Zivkovic, M., Djuric, T., Koncar, I. & Stankovic, A. The expression of renin-angiotensin-system components (ACE, ACE2 and collectrin (TMEM27)) in the human carotid plaques depending on gender and plaque phenotype, Atherosclerosis, vol. 275, p. e135, (2018).","DOI":"10.1016\/j.atherosclerosis.2018.06.395"},{"issue":"2","key":"46187_CR47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/HJH.0b013e32834f04b6","volume":"30","author":"A Soro-Paavonen","year":"2012","unstructured":"Soro-Paavonen, A. et al. Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J. Hypertens. 30 (2), 375\u2013383 (2012).","journal-title":"J. Hypertens."},{"key":"46187_CR48","first-page":"3","volume":"121","author":"MJ Soler","year":"2013","unstructured":"Soler, M. J. et al. Circulating angiotensin-converting enzyme 2 activity in kidney transplantation: a longitudinal pilot study. Nephron Clin. Pract. 121, 3\u20134 (2013). c144-c150.","journal-title":"Nephron Clin. Pract."},{"issue":"9","key":"46187_CR49","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1093\/ndt\/gft038","volume":"28","author":"MA Roberts","year":"2013","unstructured":"Roberts, M. A., Velkoska, E., Ierino, F. L. & Burrell, L. M. Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease. Nephrol. Dialysis Transplantation. 28 (9), 2287\u20132294 (2013).","journal-title":"Nephrol. Dialysis Transplantation"},{"issue":"2","key":"46187_CR50","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/1074248420967792","volume":"26","author":"HM Salah","year":"2021","unstructured":"Salah, H. M. & Mehta, J. L. Hypothesis: sex-related differences in ACE2 activity may contribute to higher mortality in men versus women with COVID-19. J. Cardiovasc. Pharmacol. Therap. 26 (2), 114\u2013118 (2021).","journal-title":"J. Cardiovasc. Pharmacol. Therap."},{"key":"46187_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0074-7742(07)79019-0","volume":"79","author":"R Bergamaschi","year":"2007","unstructured":"Bergamaschi, R. Prognostic factors in multiple sclerosis. Int. Rev. Neurobiol. 79, 423\u2013447 (2007).","journal-title":"Int. Rev. Neurobiol."},{"issue":"1\u20132","key":"46187_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2011.03.003","volume":"234","author":"JM Greer","year":"2011","unstructured":"Greer, J. M. & McCombe, P. A. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J. Neuroimmunol. 234 (1\u20132), 7\u201318 (2011).","journal-title":"J. Neuroimmunol."},{"key":"46187_CR53","doi-asserted-by":"crossref","unstructured":"Viveiros, A. et al. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones. American J. Physiology-Heart Circ. Physiology, 320, 1, pp. H296-H304, (2021).","DOI":"10.1152\/ajpheart.00755.2020"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46187-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:03:37Z","timestamp":1778583817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46187-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46187"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46187-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of the Article, Affiliation 3 contained an error. The correct affiliation is: \u201cDepartment of Clinical Pharmacy and Therapeutics, College of Pharmacy, Applied Science Private University, P.O. Box 541350, Amman 11937, Jordan.\u201d The original Article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board (IRB) at Jordan University of Science and Technology (JUST) (approval number 98\/136\/2020, date of approval December 6, 2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"A written informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"10690"}}